TRDA

TRDA CapEx to Revenue

6.89%TTM

Retrieved:

TRDA FY CapEx/Revenue%
TRDA FY CapEx/Revenue4.87%-0.52%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

TRDA capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Entrada Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
4.095%
1.4982%
4.3515%
0%
0%
0%
0%

Compare capex to revenue

All TRDA financial metrics · TRDA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.